Skip to main navigation Skip to search Skip to main content

Innate lymphoid cells in allogenic hematopoietic cell transplantation

Research output: PhD ThesisPhd-Thesis - Research and graduation internal

Abstract

Allogeneic hematopoietic cell transplantation (HCT) is often complicated by graft versus host disease (GvHD), an alloreactive immune response triggered by tissue damage. Interleukin (IL)-22 producing type 3 innate lymphoid cells (ILC3) protect epithelial tissues against chemo(radio)therapy-induced damage, suppress alloreactive T cells and mitigate acute GvHD symptoms after
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • Universiteit van Amsterdam
Supervisors/Advisors
  • Hazenberg, Mette, Supervisor
  • Blom, Bianca, Co-supervisor
Award date12 Dec 2025
Publication statusPublished - 2025

Fingerprint

Dive into the research topics of 'Innate lymphoid cells in allogenic hematopoietic cell transplantation'. Together they form a unique fingerprint.

Cite this